13F Holdings
中文EN

RKDA Arcadia Biosciences, Inc.

Beverages · Nasdaq · SEC CIK 1469443 · Fiscal year ends 12/31

Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters

Growth

TTM revenue YoY-2.1%
TTM net income YoY-101.9%
TTM EPS YoY9.4%
Revenue 3-yr CAGR3.5%
Net income 3-yr CAGR—

Margins

Gross margin41.1%
Operating margin-68.9%
Net margin-202.1%
FCF margin—
EBITDA margin-68.7%

Returns

ROE-260.8%
ROA-153.9%
ROIC (approx.)-142.0%
Asset turnover0.76x

Leverage & solvency

Liabilities / assets49.0%
Debt / equity0.00x
Current ratio3.58x
Interest coverage—

Cash quality & payout

Operating cash flow / net income0.35x
Accruals ratio-100.4%
Payout ratio—
Capex / revenue—

Factor history charts and full statement history on Pro 🔒

Financial statements

Line item FY20252025-12-31FY20242024-12-31FY20232023-12-31FY20222022-12-31FY20212021-12-31
Income statement
Revenue$4.86M$5.04M$4.45M$7.42M$6.78M
Cost of revenue$3.10M$2.96M$2.17M$6.10M$8.71M
Gross profit$1.76M$2.08M$2.28M$1.32M-$1.93M
R&D expense$9,000$53,000$64,000$1.51M$3.89M
SG&A expense$7.00M$9.64M$8.23M$15.04M$22.94M
Operating income-$2.50M-$3.65M-$6.10M-$14.01M-$35.53M
Interest expense————$20,000
Pretax income-$2.33M-$4.31M-$5.32M-$10.81M-$16.13M
Income tax$8,000$8,000$8,000$14,000$2,000
Net income-$2.34M-$7.04M-$13.98M-$15.38M-$14.66M
EBITDA-$2.47M-$3.59M-$5.99M-$13.57M-$34.60M
EPS (basic)-1.71-5.17-11.29-25.65-27.56
EPS (diluted)-1.71-5.17-11.29-25.65-27.56
Weighted avg. shares (diluted)1.37M1.36M1.24M599,389532,016
Banking
Net interest income$221,000$782,000$695,000$289,000-$20,000
Balance sheet
Cash & equivalents$259,000$4.24M$6.52M$20.64M$28.68M
Short-term investments$4.30M$0$5.12M$0—
Receivables————$1.37M
Inventory$1.21M$904,000$837,000$2.32M$4.43M
Current assets$6.36M$9.24M$14.97M$25.40M$35.39M
PP&E, net$8,000$41,000$70,000$680,000$2.29M
Intangibles$39,000$39,000$39,000$40,000$484,000
Total assets$6.55M$13.52M$19.70M$28.92M$43.92M
Current liabilities$2.06M$2.56M$3.59M$4.21M$5.04M
Short-term debt————$0
Long-term debt————$0
Total debt————$0
Total liabilities$2.41M$7.29M$7.00M$8.02M$12.72M
Shareholders' equity$4.14M$6.22M$12.84M$21.03M$31.09M
Net debt————-$28.68M
Shares outstanding1.37M1.36M1.29M616,079554,609
Cash flow statement
Operating cash flow-$4.74M-$9.63M-$15.29M-$13.98M-$25.87M
Capital expenditure$0$16,000$5,000$72,000$1.01M
Free cash flow-$4.74M-$9.64M-$15.30M-$14.05M-$26.88M
Investing cash flow$750,000$7.34M-$4.34M$1.42M$16.61M
Financing cash flow$6,000$9,000$5.51M$4.52M$21.90M
Depreciation & amortization$32,000$58,000$111,000$439,000$929,000
Stock-based compensation$234,000$512,000$717,000$1.11M$1.54M

Free plan shows the latest 5 periods; Pro shows all 12 🔒

· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.

Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.